Generic vs. Brand: Are All Makers Treated Equally? Why should makers of defective generic drugs be treated any differently than makers of defective name-brand drugs? http://www.nytimes.com/2013/03/11/opinion/hold-generic-drug-makers-accountable.html March 20th, 2013|Categories: Uncategorized| Share This Story, Choose Your Platform! FacebookTwitterLinkedInRedditTumblrPinterestVkEmail Leave A Comment Cancel replyComment Save my name, email, and website in this browser for the next time I comment.